Recombinant Measles Virus Vaccine Expressing the Nipah Virus Glycoprotein Protects against Lethal Nipah Virus Challenge

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Yoneda, Misako ^a   Georges Courbot, Marie Claude ^b   Ikeda, Fusako ^a   Ishii, Miho ^a   Nagata, Noriyo ^c   Jacquot, Frederic ^b   Raoul, Hervé ^b   Sato, Hiroki ^a   Kai, Chieko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b INSERM   (France)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE; VIRUS GLYCOPROTEIN; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MONKEY; HISTOPATHOLOGY; INFECTION PREVENTION; LUNG CONGESTION; LUNG EDEMA; LYMPHOCYTE DEPLETION; LYMPHOCYTIC INFILTRATION; NECROSIS; NIPAH VIRUS INFECTION; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RNA ANALYSIS; VACCINATION; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, VIRAL; BODY TEMPERATURE; BODY WEIGHT; BRAIN; CERCOPITHECUS AETHIOPS; CRICETINAE; GENE EXPRESSION; GENETIC VECTORS; HENIPAVIRUS INFECTIONS; IMMUNIZATION; LUNG; MEASLES VIRUS; NIPAH VIRUS; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES; VIRUS REPLICATION;

EID: 84875042120     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058414     Document Type: Article

References (33)

1. Chua KB, Bellini WJ, Rota PA, Harcourt BH, Tamin A, et al. (2000) Nipah virus: a recently emergent deadly paramyxovirus. Science 288: 1432-1435.
2. Chua KB, Goh KJ, Wong KT, Mamarulzaman A, Tan PS, et al. (1999) Fatal encephalitis due to Nipah virus among pig-farmers in Malaysis. Lancet 354, 1257-1259.
3. Hooper P, Zaki S, Daniels P, Middleton D (2001) Comparative pathology of the diseases caused by Hendra and Nipah viruses. Microbes Infect 3,315-322.
4. Kai C, Yoneda M (2011) Henipavirus Infections - An Expanding Zoonosis from Fuit Bats. J Disaster Research, in press.
5. Chadha MS, Comer JA, Lowe L, Rota PA, Rollin PE, et al. (2006) Nipah virus -associated encephalitis outbreak, Siliguri, India. Emerg Infect Dis 12, 235-240.
6. ICDDR B (2004) Person-to-person transmission of Nipah virus during outbreak in Faridpur District, 2004. Health Science Bulletin 2, 5-9.
7. Lo MK, Rota PA (2008) The emergence of Nipah virus, a highly pathogenic paramyxovirus. J Clin Virol 43, 396-400.
8. Luby SP, Hossain MJ, Gurley ES, Ahmed BN, Banu S, et al. (2009) Recurrent zoonotic transmission of Nipah virus into humans, Bangladesh, 2001-2007. Emerg Infect Dis 15, 1229-1235.
9. Goh KJ, Tan CT, Chew NK, Tan PS, Kamarulzaman A, et al. (2000) Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. N Engl J Med 342, 1229-1235.
10. Chua KB, Lam SK, Goh KJ, Hooi PS, Ksiazek TG, et al. (2001) The presence of Nipah virus in respiratory secretions and urine of patients during outbreak of Nipah virus encephalitis in Malaysia. J Infect 42, 40-43.
11. Hsu VP, Hossain MJ, Parashar DU, Ali MM, Ksiazek TG, et al. (2004) Nipah virus encephalitis reemergence, Bangladesh. Emerg Infect Dis 10, 2082-2087.
12. Paton NI, Leo YS, Zaki SR, Auchus AP, Lee KE, et al. (1999) Outbreak of Nipah-virus infection among abattoir workers in Singapore. Lancet 354, 1253-1256.
13. Wong KT, Shieh WJ, Kumar S, Norain K, Abdullah W, et al. (2002) Nipah virus pathology working group. Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis. Am J Pathol 161, 2153-2167.
14. Guillaume V, Contamin H, Loth P, Georges-Courbot MC, Lefeuvre A, et al. (2004) Nipah virus: vaccination and passive protection studies in a hamster model. J Virol 78, 834-840.
15. Weingartl HM, Berhane Y, Caswell JL, Loosmore S, Audonnet JC, et al. (2006) Recombinant Nipah virus vaccines protect pigs against challenge. J. Virol 80, 7929-7938.
16. Griffin D (2001) Measles virus. Fields virology. 4th ed. Vol 2. Philadelphia: Lippincott-Raven Publishers. 1401-1441.
17. Hilleman M (2001) Current overview of the pathogenesis and prophylaxis of measles with focus on practical implications. Vaccine 20, 651-665.
18. Ovsyannikova I, Dhiman N, Jacobson R, Vierkant R, Poland G (2003) Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine. Clin. Diagn Lab Immunol 10(3), 411-416.
19. Desprès P, Combredet C, Frenkiel M, Lorin C, Brahic M, et al. (2005) Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis. J Infect Dis, 191(2), 207-214.
20. Guerbois M, Moris A, Combredet C, Najburg V, Ruffie C, et al. (2009) Live attenuated measles vaccine expressing HIV-1 Gag virus like particles covered with gp160DeltaV1V2 is strongly immunogenic. Virology, 388, 191-203.
21. Lorin C, Mollet L, Delebecque F, Combredet C, Charneau P, et al. (2004) A single infection of recombinant measles vaccine expressing HIV-1 clade B envelope glycoproteins induces neutralizing antibodies and cellular immune responses to HIV. J Virol 78(1), 146-157.
22. Terao-Muto Y, Yoneda M, Seki T, Watanabe A, Tsukiyama-Kohara K, et al. (2008) Heparin-like glycosaminoglycans prevent the infection of measles virus in SLAM-negative cell lines. Antiviral Res. 80(3), 370-376.
23. Radecke F, Spielhofer P, Schneider H, Kaelin K, Huber M, et al. (1995) Rescue of measles viruses from cloned DNA. EMBO J, 14(23), 5773-5784.
24. Yoneda M, Guillaume V, Ikeda F, Sakuma Y, Sato H, et al. (2006) Establishment of a Nipah virus rescue system. Proc Natl Acad Sci USA., 103(44), 16508-13.
25. Wong KT, Grosjean I, Brisson C, Blanquier B, Fevre-Montange M, et al. (2003) A golden amster model for human acute Nipah virus infection. Am J Pathol, 163(5), 2127-37.
26. Lo MK, Rota PA (2008) The emergence of Nipah virus, a highly pathogenic paramyxovirus. J Clin Virol, 43(4), 396-400.
27. Geisbert TW, Daddario-DiCaprio KM, Hickey AC, Smith MA, Chan YP,et al. Development of an acute and highly pathogenic nonhuman primate model of Nipah virus infection. PLoS One, 18;5(5), e10690, 2010.
28. McEachern JA, Bingham J, Crameri G, Green DJ, Hancock TJ, et al. (2008) A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats. Vaccine, 26, 3842-3852.
29. Mungall BA, Middleton D, Crameri G, Bingham J, Halpin K, et al. (2006) Feline model of acute nipah virus infection and protection with a soluble glycoprotein-based subunit vaccine. J Virol, 80, 12293-12302.
30. Walapita P, Barr J, Sherman M, Basler CH, Wang LF (2011) Vaccine potential of Nipah virus-like particles. PLoS One, 6(4), e18437.
31. Chattopadhyay A, Rose JK (2011) Complementing defective viruses expressing separate paramyxovirus glycoproteins provide anew vaccine vector approach. J Virol, 85(5), 2004-2011.
32. Tan CT, Wong KT (2003) Nipah encephalitis outbreak in Malaysia. Annals of the Academy of Medicine, Singapore 32, 112-117.
33. Lam SK (2003) Nipah virus-a potential agent of bioterrorism? Antiviral Res, 57, 113-119.